Skip to main content

Relion Novolin 70/30 Innolet Side Effects

Generic name: insulin isophane / insulin regular

Medically reviewed by Drugs.com. Last updated on Mar 15, 2024.

Note: This document contains side effect information about insulin isophane / insulin regular. Some dosage forms listed on this page may not apply to the brand name Relion Novolin 70/30 Innolet.

Applies to insulin isophane / insulin regular: subcutaneous suspension.

Serious side effects

Along with its needed effects, insulin isophane/insulin regular may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking insulin isophane/insulin regular:

Incidence not known

Other side effects

Some side effects of insulin isophane / insulin regular may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to insulin isophane / insulin regular: subcutaneous suspension.

General

Adverse reactions observed with insulin therapy include hypoglycemia, allergic reactions, local injection site reactions, lipodystrophy, rash, pruritus, weight gain, and edema.[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Local reactions such as redness, swelling, or itching at the injection site

Very rare (less than 0.01%): Systemic reactions[Ref]

Hypersensitivity side effects have included both local and systemic reactions. Local reactions have presented as erythema, swelling, heat, or subcutaneous nodules. They usually occurred within the first two weeks of therapy and then disappear. Systemic allergy is a generalized allergy to insulin which may present as a rash over the whole body, shortness of breath, wheezing, drop in blood pressure, fast pulse, or sweating. Severe cases may be life-threatening.

There have been rare reports of patients with hypersensitivity reactions to human insulins who have tolerated insulins of animal origin.[Ref]

Cardiovascular

Frequency not reported: Peripheral edema[Ref]

Insulin may cause sodium retention and edema, especially if previously poor metabolic control is improved by intensified insulin therapy.[Ref]

Dermatologic

Uncommon (0.1% to 1%): Lipodystrophy

Frequency not reported: Rash, pruritus[Ref]

Metabolic

Very common (10% or more): Hypoglycemia[Ref]

Ocular

Frequency not reported: Refraction anomalies, temporary worsening of diabetic retinopathy[Ref]

Refraction anomalies may occur upon initiation of insulin; symptoms are usually transient. Intensification of insulin therapy may be associated with temporary worsening of diabetic retinopathy.[Ref]

Local

Frequency not reported: Injection site reactions[Ref]

Injection site reactions including pain, redness, hives, inflammation, bruising, swelling, and itching, may occur. These reactions are usually transitory and may be related to factors other than insulin, such as irritants in the skin cleansing agent or poor injection technique.[Ref]

Other

Frequency not reported: Weight gain[Ref]

Weight gain has been attributed to the anabolic effects of insulin and the decrease in glycosuria.[Ref]

Immunologic

Frequency not reported: Anti-insulin antibodies[Ref]

Nervous system

Frequency not reported: Acute painful neuropathy[Ref]

Fast improvement in blood glucose has been associated with acute painful neuropathy, which is generally reversible.[Ref]

Frequently asked questions

More about Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular)

Patient resources

Other brands

Novolin 70/30, Humulin 70/30, Humulin 50/50, Humulin 70/30 Pen

Professional resources

Other brands

Novolin 70/30, Humulin 70/30

Other formulations

Related treatment guides

References

1. Product Information. Humulin 70/30 (insulin isophane-insulin regular). Lilly, Eli and Company. 2002.

2. Cerner Multum, Inc. Australian Product Information.

3. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.